SNM Members Receive IND Approval

February 4, 2011

SNM Members Receive IND Approval

SNM members, Michelle Bradbury, PhD, MD; Steve Larson, MD; Pat Zanzonico, PhD; and Heiko Schöder, MD, along with their colleagues, received approval for their first Investigational New Drug Application (IND) from the US Food and Drug Administration (FDA) for an ultrasmall silica inorganic nanoparticle platform for targeted molecular imaging of cancer, which may be useful for cancer treatment in the future.